Evidence map›Paper›PMID 30371155›Full record

ArticleJournal of the American Heart Association2018

Potential for Rapid and Cost-Effective Cardiac Magnetic Resonance in the Developing (and Developed) World.

Christopher M Kramer

Abstract readEditorialComment
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Christopher M Kramer1 Departments of Medicine and Radiology and the Cardiovascular Imaging Center University of Virginia Health System Charlottesville VA.

Funding

HCMR Novel Markers of Prognosis in Hypertrophic CardiomyopathyU01HL117006 · NHLBI · UNIVERSITY OF VIRGINIA · PI KRAMER, CHRISTOPHER M., NEUBAUER, STEFAN · 2013 to 2017
$14.5M
NHLBI NIH HHS U01 HL117006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GadoliniumMagnetic Resonance SpectroscopyPeruGadoliniumcardiomyopathyEditorialsgadoliniummagnetic resonance imaging

Identifiers

PMID30371155
PMCPMC6201413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.